reports
Moody's places Chemours' ratings under review for downgrade
Moody's Investors Service (Moody's) has placed under review for downgrade The Chemours Company's ("Chemours") Ba3 corporate family rating ("CFR"), Ba3-PD probability of default rating ("PDR"), Ba1 rating on its senior secured credit facilities, and the B1 rating on its senior unsecured notes. Previo...
- Dave Nicoski
- Ross LaDuke
Vital Signs: Actionable charts
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
SBH SALLY BEAUTY HOLDINGS INC.
NCLH NORWEGIAN CRUISE LINE HOLDINGS LTD.
LMNR LIMONEIRA CO.
AMWD CARTHAGE CEMENT
CC AMERICAN WOODMARK CORPORATION
PAGS CHEMOURS CO.
GLOB PAGSEGURO DIGITAL LTD
LYFT GAZIT-GLOBE LTD.
VIACA LYFT
JOBY VIACOMCBS INC
METBV JOBY AVIATION INC
QUICKTOU RAMACO RESOURCES INC.
QUICKTOUCH TECHNOLOGIES LTD.
- Valens Research
CC - Valens Credit Report - 2023 11 20
Credit markets are grossly overstating CC's credit risk with a YTW of 9.084% relative to an Intrinsic YTW of 6.454%, while CDS markets are materially overstating credit risk with a CDS of 355bps relative to an Intrinsic CDS of 180bps. Furthermore, Moody's is overstating the company's fundamental credit risk, with its speculative Ba3 credit rating three notches lower than Valens' XO (Baa3) credit rating. Incentives Dictate Behavior™ analysis highlights mostly positive signals for creditors. CC's...
- Valens Research
- Valens Research
CC - Valens Credit Report - 2023 08 14
Credit markets are materially overstating CC's credit risk with a YTW of 7.737% relative to an Intrinsic YTW of 5.716%, while CDS markets are overstating credit risk with a CDS of 255bps relative to an Intrinsic CDS of 157bps. Furthermore, Moody's is overstating the company's fundamental credit risk, with it speculative Ba3 credit rating three notches lower than Valens' XO (Baa3) credit rating. Incentives Dictate Behavior™ analysis highlights mostly positive signals for creditors. CC's compensa...
Moody's assigns Ba1 to Chemours' term loans; outlook stable
Moody's Investors Service (Moody's) has assigned a Ba1 rating to The Chemours Company's ("Chemours") upsized and amended and extended $960 million Senior Secured Term Loan B3 due 2028 and €515 million Senior Secured Term Loan B3 due 2028. Proceeds from the issuance will be used to repay Chemours' ex...
Chemours Co: 2 directors
Two Directors at Chemours Co bought/sold after exercising options 12,786 shares at between 32.300USD and 32.630USD. The significance rating of the trade was 50/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the c...
- Valens Research
CC - Valens Credit Report - 2023 05 09
Credit markets are grossly overstating CC's credit risk with a YTW of 8.024% relative to an Intrinsic YTW of 5.184%, while CDS markets are materially overstating credit risk with a CDS of 363bps relative to an Intrinsic CDS of 172bps. Furthermore, Moody's is overstating the company's fundamental credit risk, with it speculative Ba3 credit rating three notches lower than Valens' XO (Baa3) credit rating. Incentive Dictate Behavior™ analysis highlights mostly positive signals for creditors. CC's c...
- Valens Research
CC - Valens Credit Report - 2023 03 06
Credit markets are grossly overstating CC's credit risk with a YTW of 8.420% relative to an Intrinsic YTW of 5.720%, while CDS markets are materially overstating credit risk with a CDS of 389bps relative to an Intrinsic CDS of 156bps. Furthermore, Moody's is overstating the company's fundamental credit risk, with it speculative Ba3 credit rating three notches lower than Valens' XO (Baa3) credit rating. Incentive Dictate Behavior™ analysis highlights mostly positive signals for creditors. CC's c...
- Valens Research
- Valens Research
CC - Valens Credit Report - 2022 11 30
Credit markets are grossly overstating CC's credit risk with a YTW of 7.749% and a CDS of 379bps, relative to an Intrinsic YTW of 4.320% and an Intrinsic CDS of 154bps. Furthermore, Moody's is materially overstating the company's fundamental credit risk, with its speculative Ba3 credit rating five notches lower than Valens' IG4+ (Baa1) credit rating. Incentive Dictate Behavior™ analysis highlights mostly positive signals for creditors. CC's compensation framework incentivizes management to impr...
Moody's changes Chemours outlook to stable
Moody's Investors Service ("Moody's") affirmed the existing ratings of The Chemours Company ("Chemours"), including its Ba3 corporate family rating ("CFR"), Ba1 rating on its senior secured credit facilities, and the B1 rating on its senior unsecured notes. Moody's also changed Chemours' outlook to ...
Moody's changes Chemours outlook to stable
Moody's Investors Service ("Moody's") affirmed the existing ratings of The Chemours Company ("Chemours"), including its Ba3 corporate family rating ("CFR"), Ba1 rating on its senior secured credit facilities, and the B1 rating on its senior unsecured notes. Moody's also changed Chemours' outlook to...
- Valens Research
CC - Valens Credit Report - 2022 08 31
Credit markets are materially overstating CC's credit risk with a YTW of 6.750% and a CDS of 323bps, relative to an Intrinsic YTW of 4.330% and an Intrinsic CDS of 122bps. Furthermore, Moody's is materially overstating the company's fundamental credit risk, with its speculative Ba3 credit rating five notches lower than Valens' IG4+ (Baa1) credit rating. Incentive Dictate Behavior™ analysis highlights mostly positive signals for creditors. CC's compensation framework incentivizes management to i...
- Valens Research
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.